Acute Uveitis following COVID-19 Vaccination

To describe a case of juvenile idiopathic arthritis (JIA)-associated anterior uveitis after receiving the Sinopharm COVID-19 vaccine. A retrospective case report. An 18-year-old girl, with a history of antinuclear antibody positive oligoarticular JIA, presented with bilateral anterior uveitis 5 days...

Full description

Saved in:
Bibliographic Details
Published inOcular immunology and inflammation Vol. 29; no. 6; pp. 1207 - 1209
Main Authors ElSheikh, Reem H., Haseeb, Abid, Eleiwa, Taher K., Elhusseiny, Abdelrahman M.
Format Journal Article
LanguageEnglish
Published England Taylor & Francis 18.08.2021
Subjects
Acute Disease
Administration, Ophthalmic
Adolescent
COVID-19 - prevention & control
COVID-19 Vaccines - adverse effects
Female
Glucocorticoids - administration & dosage
Humans
Ophthalmic Solutions
Retrospective Studies
SARS-CoV-2
Tomography, Optical Coherence
Uveitis, Anterior - diagnosis
Uveitis, Anterior - drug therapy
Uveitis, Anterior - etiology
Vaccination - adverse effects
Visual Acuity - physiology
Online AccessGet full text
ISSN0927-3948
1744-5078
1744-5078
DOI10.1080/09273948.2021.1962917

Cover

Abstract To describe a case of juvenile idiopathic arthritis (JIA)-associated anterior uveitis after receiving the Sinopharm COVID-19 vaccine. A retrospective case report. An 18-year-old girl, with a history of antinuclear antibody positive oligoarticular JIA, presented with bilateral anterior uveitis 5 days after the second dose of the Sinopharm COVID-19 vaccine. Ocular examination revealed anterior uveitis with reduced visual acuity in both eyes. Anterior segment optical coherence tomography showed hyperreflective dots in the anterior chamber (AC) and fine endothelial granularities representing the circulating cells in the AC. Uveitis in both eyes resolved gradually after topical steroid treatment without recurrence. This report demonstrates a potential causal association of COVID-19 vaccine with anterior uveitis.
AbstractList To describe a case of juvenile idiopathic arthritis (JIA)-associated anterior uveitis after receiving the Sinopharm COVID-19 vaccine.PURPOSETo describe a case of juvenile idiopathic arthritis (JIA)-associated anterior uveitis after receiving the Sinopharm COVID-19 vaccine.A retrospective case report.METHODSA retrospective case report.An 18-year-old girl, with a history of antinuclear antibody positive oligoarticular JIA, presented with bilateral anterior uveitis 5 days after the second dose of the Sinopharm COVID-19 vaccine. Ocular examination revealed anterior uveitis with reduced visual acuity in both eyes. Anterior segment optical coherence tomography showed hyperreflective dots in the anterior chamber (AC) and fine endothelial granularities representing the circulating cells in the AC. Uveitis in both eyes resolved gradually after topical steroid treatment without recurrence.RESULTSAn 18-year-old girl, with a history of antinuclear antibody positive oligoarticular JIA, presented with bilateral anterior uveitis 5 days after the second dose of the Sinopharm COVID-19 vaccine. Ocular examination revealed anterior uveitis with reduced visual acuity in both eyes. Anterior segment optical coherence tomography showed hyperreflective dots in the anterior chamber (AC) and fine endothelial granularities representing the circulating cells in the AC. Uveitis in both eyes resolved gradually after topical steroid treatment without recurrence.This report demonstrates a potential causal association of COVID-19 vaccine with anterior uveitis.CONCLUSIONThis report demonstrates a potential causal association of COVID-19 vaccine with anterior uveitis.
To describe a case of juvenile idiopathic arthritis (JIA)-associated anterior uveitis after receiving the Sinopharm COVID-19 vaccine. A retrospective case report. An 18-year-old girl, with a history of antinuclear antibody positive oligoarticular JIA, presented with bilateral anterior uveitis 5 days after the second dose of the Sinopharm COVID-19 vaccine. Ocular examination revealed anterior uveitis with reduced visual acuity in both eyes. Anterior segment optical coherence tomography showed hyperreflective dots in the anterior chamber (AC) and fine endothelial granularities representing the circulating cells in the AC. Uveitis in both eyes resolved gradually after topical steroid treatment without recurrence. This report demonstrates a potential causal association of COVID-19 vaccine with anterior uveitis.
Author Elhusseiny, Abdelrahman M.
Haseeb, Abid
ElSheikh, Reem H.
Eleiwa, Taher K.
Author_xml – sequence: 1
  givenname: Reem H.
  surname: ElSheikh
  fullname: ElSheikh, Reem H.
  organization: Cairo University Hospitals
– sequence: 2
  givenname: Abid
  surname: Haseeb
  fullname: Haseeb, Abid
  organization: University of Illinois at Chicago
– sequence: 3
  givenname: Taher K.
  orcidid: 0000-0003-3107-2106
  surname: Eleiwa
  fullname: Eleiwa, Taher K.
  organization: Benha University
– sequence: 4
  givenname: Abdelrahman M.
  orcidid: 0000-0003-1412-375X
  surname: Elhusseiny
  fullname: Elhusseiny, Abdelrahman M.
  email: Abdelrahman.Elhusseiny@childrens.harvard.edu
  organization: Harvey and Bernice Jones Eye Institute, University of Arkansas for Medical Sciences
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34379565$$D View this record in MEDLINE/PubMed
BookMark eNqFkD1PwzAQQC1URD_gJ4A6MpBythMnFgtV-apUqUvparmOjYySuNgpVf89CW0ZGGC65b073eujTuUqjdAlhhGGDG6Bk5TyOBsRIHiEOSMcpyeoh9M4jhJIsw7qtUzUQl3UD-EdAGLO8Rnq0pimPGFJD92M1abWw9dPbWsbhsYVhdva6m04mS-nDxHmw6VUylaytq46R6dGFkFfHOYALZ4eF5OXaDZ_nk7Gs0hRxuqI5YZQg3EOBrJsRVPJCGkOJylR2vCMkJxSyBlmWkoa5xiA4TQjCjTnHOgAXe_Xrr372OhQi9IGpYtCVtptgiAJg4wmlJEGvTqgm1Wpc7H2tpR-J44PNkCyB5R3IXhtfhAMog0pjiFFG1IcQjbe3S9P2fo7Qu2lLf617_e2rYzzpdw6X-SilrvCeeNlpWwQ9O8VX_89h78
CitedBy_id crossref_primary_10_1136_bcr_2021_248441
crossref_primary_10_1002_ccr3_8181
crossref_primary_10_1016_j_ajo_2022_02_011
crossref_primary_10_3390_microorganisms11092220
crossref_primary_10_1007_s40278_022_10516_2
crossref_primary_10_4103_ojo_ojo_237_22
crossref_primary_10_1016_j_ajoc_2022_101726
crossref_primary_10_1186_s12348_023_00358_x
crossref_primary_10_1080_09273948_2022_2039211
crossref_primary_10_1186_s12348_022_00294_2
crossref_primary_10_5812_semj_141979
crossref_primary_10_3390_vaccines11010069
crossref_primary_10_1080_17469899_2022_2066523
crossref_primary_10_1016_j_jaut_2022_102925
crossref_primary_10_1155_2023_8845850
crossref_primary_10_1159_000539608
crossref_primary_10_3390_vaccines10020342
crossref_primary_10_1080_09273948_2023_2189456
crossref_primary_10_2147_OPTH_S336963
crossref_primary_10_1177_23247096221086450
crossref_primary_10_1080_21645515_2022_2138051
crossref_primary_10_1080_09273948_2022_2093754
crossref_primary_10_1080_09273948_2023_2239338
crossref_primary_10_1186_s12886_022_02747_7
crossref_primary_10_3389_fpubh_2022_1051378
crossref_primary_10_1002_eer3_70000
crossref_primary_10_1080_09273948_2022_2093757
crossref_primary_10_1016_j_pdpdt_2022_102742
crossref_primary_10_1186_s12348_022_00298_y
crossref_primary_10_1080_09273948_2023_2200858
crossref_primary_10_1097_WNO_0000000000001537
crossref_primary_10_1007_s10792_023_02684_4
crossref_primary_10_1080_09273948_2021_1985524
crossref_primary_10_1080_09273948_2022_2059522
crossref_primary_10_1016_j_ophtha_2022_12_013
crossref_primary_10_4103_ojo_ojo_212_22
crossref_primary_10_2478_rir_2022_0019
crossref_primary_10_1016_j_jfo_2023_06_002
crossref_primary_10_4103_joco_joco_41_22
crossref_primary_10_1016_j_jfo_2024_104265
crossref_primary_10_1080_09273948_2022_2069127
crossref_primary_10_1016_j_ijid_2021_09_075
crossref_primary_10_3390_vaccines11010166
crossref_primary_10_4103_ijo_IJO_1089_22
crossref_primary_10_3389_fmed_2022_999251
crossref_primary_10_3390_vaccines10101767
crossref_primary_10_1080_09273948_2023_2220782
crossref_primary_10_1186_s12348_023_00342_5
crossref_primary_10_1186_s12348_021_00275_x
crossref_primary_10_1186_s12879_021_06690_8
crossref_primary_10_3390_vaccines10111879
crossref_primary_10_3390_vaccines10111878
crossref_primary_10_1007_s40123_021_00415_5
crossref_primary_10_1007_s00011_021_01506_6
crossref_primary_10_3390_medicina60020249
crossref_primary_10_1016_j_clindermatol_2023_10_008
crossref_primary_10_3389_fmed_2022_1019434
crossref_primary_10_3390_vaccines10101758
Cites_doi 10.1371/journal.pone.0241661
10.1016/j.jaapos.2020.05.002
10.1007/s40123-021-00338-1
10.1001/jamaophthalmol.2020.1291
10.1016/j.cell.2020.06.008
10.1016/S1473-3099(20)30831-8
10.1016/j.jaapos.2021.05.003
10.1038/s41433-020-0905-1
10.15585/mmwr.mm7017e4
10.1136/bjophthalmol-2021-319338
ContentType Journal Article
Copyright 2021 Taylor & Francis Group, LLC 2021
Copyright_xml – notice: 2021 Taylor & Francis Group, LLC 2021
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1080/09273948.2021.1962917
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1744-5078
EndPage 1209
ExternalDocumentID 34379565
10_1080_09273948_2021_1962917
1962917
Genre Letter to the Editor
Journal Article
Case Reports
GroupedDBID ---
00X
03L
0BK
0R~
123
29N
36B
4.4
AALUX
AAMIU
AAPUL
AAQRR
AAWTL
ABBKH
ABDBF
ABEIZ
ABJNI
ABLIJ
ABLKL
ABUPF
ABXYU
ACENM
ACGEJ
ACGFS
ACIEZ
ACUHS
ADCVX
ADRBQ
ADXPE
AECIN
AENEX
AEOZL
AFKVX
AGDLA
AGFJD
AGRBW
AGYJP
AIJEM
AIRBT
AJWEG
AKBVH
ALMA_UNASSIGNED_HOLDINGS
ALQZU
ALYBC
AMDAE
BABNJ
BLEHA
BOHLJ
CCCUG
CS3
DKSSO
DU5
EAP
EBC
EBD
EBS
EMB
EMK
EMOBN
EPL
ESX
F5P
H13
HZ~
KRBQP
KSSTO
KWAYT
KYCEM
LJTGL
M4Z
O9-
P2P
RNANH
RVRKI
SV3
TBQAZ
TDBHL
TERGH
TFDNU
TFL
TFW
TUROJ
TUS
UEQFS
V1S
~1N
AAGDL
AAYXX
ABWVI
AFRVT
CITATION
TASJS
ADYSH
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c366t-6df23f11d0f088b37a622991572cef9822d330d616eaa34d10061782c0e99903
ISSN 0927-3948
1744-5078
IngestDate Wed Oct 01 14:05:50 EDT 2025
Wed Feb 19 02:26:48 EST 2025
Wed Oct 01 01:15:10 EDT 2025
Thu Apr 24 22:57:13 EDT 2025
Wed Dec 25 09:06:42 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 6
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c366t-6df23f11d0f088b37a622991572cef9822d330d616eaa34d10061782c0e99903
Notes ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ORCID 0000-0003-1412-375X
0000-0003-3107-2106
PMID 34379565
PQID 2560835362
PQPubID 23479
PageCount 3
ParticipantIDs pubmed_primary_34379565
proquest_miscellaneous_2560835362
crossref_primary_10_1080_09273948_2021_1962917
informaworld_taylorfrancis_310_1080_09273948_2021_1962917
crossref_citationtrail_10_1080_09273948_2021_1962917
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-08-18
PublicationDateYYYYMMDD 2021-08-18
PublicationDate_xml – month: 08
  year: 2021
  text: 2021-08-18
  day: 18
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Ocular immunology and inflammation
PublicationTitleAlternate Ocul Immunol Inflamm
PublicationYear 2021
Publisher Taylor & Francis
Publisher_xml – name: Taylor & Francis
References cit0011
cit0001
cit0010
Benage M (cit0012) 2016; 113
cit0008
cit0009
Meo SA (cit0005) 2021; 25
cit0006
cit0007
cit0004
cit0002
cit0003
References_xml – ident: cit0001
  doi: 10.1371/journal.pone.0241661
– volume: 113
  start-page: 48
  year: 2016
  ident: cit0012
  publication-title: Mo Med
– ident: cit0003
  doi: 10.1016/j.jaapos.2020.05.002
– ident: cit0011
  doi: 10.1007/s40123-021-00338-1
– ident: cit0002
  doi: 10.1001/jamaophthalmol.2020.1291
– ident: cit0007
  doi: 10.1016/j.cell.2020.06.008
– ident: cit0008
  doi: 10.1016/S1473-3099(20)30831-8
– volume: 25
  start-page: 1663
  issue: 3
  year: 2021
  ident: cit0005
  publication-title: Eur Rev Med Pharmacol Sci
– ident: cit0010
  doi: 10.1016/j.jaapos.2021.05.003
– ident: cit0004
  doi: 10.1038/s41433-020-0905-1
– ident: cit0006
  doi: 10.15585/mmwr.mm7017e4
– ident: cit0009
  doi: 10.1136/bjophthalmol-2021-319338
SSID ssj0004991
Score 2.5095642
Snippet To describe a case of juvenile idiopathic arthritis (JIA)-associated anterior uveitis after receiving the Sinopharm COVID-19 vaccine. A retrospective case...
To describe a case of juvenile idiopathic arthritis (JIA)-associated anterior uveitis after receiving the Sinopharm COVID-19 vaccine.PURPOSETo describe a case...
SourceID proquest
pubmed
crossref
informaworld
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1207
SubjectTerms Acute Disease
Administration, Ophthalmic
Adolescent
COVID-19 - prevention & control
COVID-19 Vaccines - adverse effects
Female
Glucocorticoids - administration & dosage
Humans
Ophthalmic Solutions
Retrospective Studies
SARS-CoV-2
Tomography, Optical Coherence
Uveitis, Anterior - diagnosis
Uveitis, Anterior - drug therapy
Uveitis, Anterior - etiology
Vaccination - adverse effects
Visual Acuity - physiology
Title Acute Uveitis following COVID-19 Vaccination
URI https://www.tandfonline.com/doi/abs/10.1080/09273948.2021.1962917
https://www.ncbi.nlm.nih.gov/pubmed/34379565
https://www.proquest.com/docview/2560835362
Volume 29
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVEBS
  databaseName: EBSCOhost Academic Search Ultimate
  customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn
  eissn: 1744-5078
  dateEnd: 20241003
  omitProxy: true
  ssIdentifier: ssj0004991
  issn: 0927-3948
  databaseCode: ABDBF
  dateStart: 19970301
  isFulltext: true
  titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn
  providerName: EBSCOhost
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELegkxAviO-VLwUJ8TJSJbYbJ48dazVgWx9Ip75ZiWOrEV06aMoEfz1nx0karWgDVYoqt5dad9fL73xfCL1TkWBeKKlLqMQuZV7khpFSLk1JKFKPZmlqsnzPguMZ_TwfztsSAlNdUqYD8XtnXcn_SBXWQK66SvYfJNvcFBbgPcgXriBhuN5KxiOho_yzn1I3JjpQINLVlYnjT88_Hbl-dHCeCJEXLfMtCp3a5FNdG7Ldg0mBelx0QvPj5deFzL8tKknIi61aBnj8SRPMGaV1Vrz-vsyvDB6NE50_8qX9YLFZr2Ve_KpIMrkEM6cDCKfbBw_YnKR2bCWj1AU4WS3JHWvWwNojjfyatfRxNfH2mhm3eY8RYKvIJOBhfwCmAkdVnWe3bfbZlE9mJyc8Hs_j95ffXT1RTEfe7XiVu2gPsyDAPbQ3Ojw6nLRVs5GZp9hsua7v0p3Xd_1yB7l0-tr-3TsxKCV-iB5Y98IZVbryCN2RxWN079QmUDxBH4zKOFZlnEZlnFplnC2VeYriyTj-eOzagRmuIEFQukGmMFG-n3kKHh4pYUmAAW74Q4aFVLpTY0aIlwV-IJOE0Mw3ADbEwpPgJ3jkGeoVq0LuI8dTEZPwAvgWGqueMjUMGezAZyqjoo9ozQsubDN5PdNkyf2656xlIdcs5JaFfTRoyC6rbio3EUTbjOalOcZS1cwZTm6gfVtLhYPN1IGwpJCrzZprmA-eB2C3PnpeiavZDtENOsHLeXEL6pfofvvHeIV65Y-NfA0YtUzfWGX7A80bhuM
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Acute+Uveitis+following+COVID-19+Vaccination&rft.jtitle=Ocular+immunology+and+inflammation&rft.au=ElSheikh%2C+Reem+H&rft.au=Haseeb%2C+Abid&rft.au=Eleiwa%2C+Taher+K&rft.au=Elhusseiny%2C+Abdelrahman+M&rft.date=2021-08-18&rft.issn=1744-5078&rft.eissn=1744-5078&rft.volume=29&rft.issue=6&rft.spage=1207&rft_id=info:doi/10.1080%2F09273948.2021.1962917&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0927-3948&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0927-3948&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0927-3948&client=summon